Rinath Jeselsohn M.D. Dr. Jeselsohn is a medical oncologist and physician scientist whose research work focuses on mechanisms of treatment resistance and tumor progression in hormone receptor positive breast cancer. She is an Assistant Professor of Medicine in the Department of Medical Oncology, Division of Molecular and Cellular Oncology and the Breast Oncology Center at the Dana Farber Cancer Institute. Dr. Jeselsohn obtained her M.D. degree from the Hebrew University in Jerusalem. She did her residency in Internal Medicine in the University of Texas SA, Health Science Center and Fellowship in Heme/Onc at Tufts Medical Center. After the completion of her clinical training, she trained in the lab Dr. Myles Brown at the Dana Farber Cancer Institute.
Zsuzsanna Nagy Ph.D. Research Associate Zsuzsi is a scientist in Medicine at Dana-Farber Cancer Institute and Harvard Medical School. She received her Master’s and PhD degree in biomedical sciences from the University of Debrecen (Debrecen, Hungary). She then completed her postdoctoral studies at the Macquarie University and Children’s Cancer Institute in Sydney, Australia. Zsuzsi’s is currently investigating the epigenetic factors underlying the action of acquired therapy resistance in breast cancer. Her main research project focuses on characterizing the activity of ESR1 fusions in estrogen receptor positive breast cancer.
Capucine Heraud Ph.D. Research Associate Capucine's research is focused on breast cancer and the need to find new biomarkers and effective cancer therapies through the analysis of CDK inhibitors. Capucine received her BS in Cell Biology from the University of Nantes, and her MS and PhD in Cell Biology and Pathophysiology from the University of Bordeaux. In her spare time, Capucine enjoys cooking and doing yoga.
Genevra Kuziel Ph.D. Postdoctoral Research Fellow Genevra attended Reed College for an undergraduate degree in Biology and UW - Madison for a graduate degree in Cancer Biology. Her research is currently focused on using mouse models of hormone receptor positive breast cancer, in part to better understand the role of the immune microenvironment and function of immunotherapy in this breast cancer subtype. Outside of lab, she enjoys cooking, cycling, and rock climbing.
Qi Zhang M.D., Ph.D. Postdoctoral Research Fellow/Visiting Scholar Qi received her Ph.D. and master's degree in oncology and bachelor's degree in clinical medicine from Fudan University, Shanghai, China. She was also a breast cancer surgeon for her residency training at Shanghai Cancer Center. For basic and translational research, she mainly focuses on understanding the mechanism of HER2 targeted therapy in breast cancer and exploring new treatment strategy for HER2 treatment resistance. Qi is currently a postdoctoral fellow at Fudan University Shanghai Center and a visiting scholar in Jeselsohn lab.
Douglas Russo M.S. Computational Analyst/Statistician Douglas holds a B.S. in Mathematics and Physics from Northeastern University and an M.S. in Statistics from Stanford University. His interests are in applied statistics for high-dimensional and genomic data.
Kavya Prasad M.S. Associate Computational Biologist II Kavya joined the lab as an Associate Computational Biologist II in July 2022. She completed her MS in Computational Biology at Carnegie Mellon University, Pittsburgh and her Bachelors of Technology in Bioinformatics in India. She is currently working on analysing genomic and transcriptomic data from the PELOPS clinical trial as a joint project with the Getz lab at Broad Institute. Aside from work, she is a carnatic music vocalist, and also enjoys scrabble and chess in her free time.
Alumni Agostina Nardone Ph.D. Cristina Guarducci Ph.D. Francisco Hermida Prado Ph.D. Shira Sherman M.D. Albert Grinshpun M.D. Wen Ma M.D.